Pharmaceuticals · VANCOUVER, A1, British Columbia, Canada
$7.10
-3.95% (-$0.29)2026-07-08
Smart-Money SignalNeutral · 50/100— Insiders are net buyers over 90 days ($143K, 4 buys vs 1 sale)
Revenue$8.3M
Net Income-$43.2M
EPS$-0.14
Market Cap$2.2B
Price Performance
Historical data including institutional events
Company Profile
C
Carl Hansen
CEO & Executive Director
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
